Fatal myelofibrosis following fludarabine administration in a patient withindolent lymphoma

Citation
L. Palomera et al., Fatal myelofibrosis following fludarabine administration in a patient withindolent lymphoma, HAEMATOLOG, 83(11), 1998, pp. 1045-1046
Citations number
7
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
HAEMATOLOGICA
ISSN journal
03906078 → ACNP
Volume
83
Issue
11
Year of publication
1998
Pages
1045 - 1046
Database
ISI
SICI code
0390-6078(199811)83:11<1045:FMFFAI>2.0.ZU;2-A
Abstract
We report a case of fulminant myelofibrosis after administration of fludara bine in a patient diagnosed as having refractory low-grade lymphoma, progre ssing fatally. Myelofibrosis in the setting of an indolent lymphoma is very rare; this fact, and the short period between drug administration and fibr osis suggest an etiopathogenic link, although this potential and severe adv erse effect of fludarabine has not been previously reported in the literatu re.